AI assistant
REGENXBIO Inc. — Director's Dealing 2017
Jun 22, 2017
32827_dirs_2017-06-22_f35769da-ae9c-4ca7-881c-17ec0b0aea78.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENXBIO Inc. (RGNX)
CIK: 0001590877
Period of Report: 2017-06-20
Reporting Person: Mills Kenneth T. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-06-20 | Common Stock | S | 5604.00 | $19.60 | Disposed | 119396.00 | Direct |
| 2017-06-20 | Common Stock | S | 896.00 | $20.16 | Disposed | 118500.00 | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
F2: This transaction was executed in multiple trades at prices ranging from $19.00 to $19.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $20.05 to $20.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.